Atossa Therapeutics Inc (ATOS)

01:00 AM

Atossa Therapeutics (ATOS) Reports Wider-Than-Expected Loss - GuruFocus

01:00 AM

Mar 25, 2026

Atossa Therapeutics 2025 Annual Report: (Z)-Endoxifen Clinical Development, Intellectual Property, and Regulatory Strategy - Minichart

Mar 25, 2026

Mar 25, 2026

ATOS Stock Drops After Hours On Earnings Miss — CEO Now Bets On New Uses For Its Experimental Cancer Drug - Stocktwits

Mar 25, 2026

Mar 25, 2026

ATOS Advances in Drug Development with Strategic Focus - GuruFocus

Mar 25, 2026

Mar 25, 2026

ATOSSA THERAPEUTICS INC reports Q4 and full year 2025 results and unveils corporate update - Traders Union

Mar 25, 2026

Mar 25, 2026

Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update - PR Newswire

Mar 25, 2026

Mar 25, 2026

Atossa Therapeutics 2025 10-K: $0.0M Revenue; Net loss $34.8M - TradingView

Mar 25, 2026

Mar 25, 2026

Atossa Therapeutics (NASDAQ: ATOS) boosts cash options but warns on going concern - Stock Titan

Mar 25, 2026

Mar 25, 2026

R&D spending jumps as Atossa (NASDAQ: ATOS) advances (Z)-endoxifen programs - Stock Titan

Mar 25, 2026

Mar 20, 2026

Atossa Therapeutics (NASDAQ: ATOS) asks shareholders to OK 2:1–20:1 reverse split - Stock Titan

Mar 20, 2026

Mar 20, 2026

Atossa Therapeutics Inc expected to post a loss of $1.14 a shareEarnings Preview - TradingView

Mar 20, 2026

Mar 20, 2026

ATOS Stock Price, Quote & Chart | ATOSSA THERAPEUTICS INC (NASDAQ:ATOS) - ChartMill

Mar 20, 2026

Mar 19, 2026

Atossa Therapeutics Appoints Two New Medical Directors in Breast Oncology and Rare Diseases - Contract Pharma

Mar 19, 2026

Mar 19, 2026

The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology - The Globe and Mail

Mar 19, 2026

Mar 19, 2026

Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives - Yahoo Finance

Mar 19, 2026

Mar 15, 2026

Should I set a stop loss on Atossa Therapeutics Inc2026 Decliners & Growth Focused Stock Pick Reports - baoquankhu1.vn

Mar 15, 2026

Mar 13, 2026

Atossa Therapeutics announces launch of early-stage DMD program for rare disease awareness - Traders Union

Mar 13, 2026

Mar 13, 2026

Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference - Sahm

Mar 13, 2026

Mar 12, 2026

Atossa presents preclinical data on endoxifen for muscular dystrophy - Investing.com South Africa

Mar 12, 2026

Mar 12, 2026

Atossa presents preclinical data on endoxifen for muscular dystrophy By Investing.com - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Atossa Therapeutics, Inc. Presents Clinical Trial Update On Z-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference - marketscreener.com

Mar 12, 2026

Mar 12, 2026

Atossa Therapeutics shares clinical trial update for Z-endoxifen at MDA conference - Traders Union

Mar 12, 2026

Mar 12, 2026

Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference (2026-03-12) - Seeking Alpha

Mar 12, 2026

Mar 11, 2026

Big Money Moves: Is Atossa Therapeutics Inc a potential multi bagger2026 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Mar 11, 2026

Mar 10, 2026

Muscle biomarker improvement reported in dystrophic mice, Atossa Therapeutics asserts - Traders Union

Mar 10, 2026

Mar 07, 2026

Is Atossa Therapeutics Inc likely to announce a buybackJuly 2025 Momentum & Reliable Entry Point Alerts - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

Hedge Fund Moves: Is Atossa Therapeutics Inc stock undervalued right nowJuly 2025 EndofMonth & Long-Term Safe Return Strategies - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

CEO Moves: Is Atossa Therapeutics Inc a speculative investmentQuarterly Market Summary & Smart Swing Trading Alerts - baoquankhu1.vn

Mar 05, 2026

Mar 03, 2026

Cash from operating activities of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Mar 03, 2026

Mar 03, 2026

Cash from financing activities of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Mar 03, 2026

Mar 03, 2026

Free cash flow of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Mar 03, 2026

Mar 03, 2026

Aug Fed Impact: Is Atossa Therapeutics Inc stock undervalued right nowQuarterly Profit Summary & Daily Growth Stock Investment Tips - baoquankhu1.vn

Mar 03, 2026

Mar 03, 2026

Total liabilities & shareholders' equities of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Mar 03, 2026

Mar 03, 2026

Atossa Therapeutics advances Z-endoxifen platform in oncology and DMD targeting molecular precision - Traders Union

Mar 03, 2026

Feb 28, 2026

ATOS PE Ratio & Valuation, Is ATOS Overvalued - Intellectia AI

Feb 28, 2026

Feb 26, 2026

Is Atossa Therapeutics Inc. stock influenced by commodity pricesJuly 2025 Recap & Daily Profit Focused Screening - mfd.ru

Feb 26, 2026

Feb 26, 2026

ATOS Should I Buy - Intellectia AI

Feb 26, 2026

Feb 24, 2026

ATOS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 23, 2026

Atossa Therapeutics outlines Z-Endoxifen strategy for breast cancer prevention - Traders Union

Feb 23, 2026

Feb 21, 2026

Atossa Therapeutics Launches New $50 Million ATM Program - The Globe and Mail

Feb 21, 2026

Feb 20, 2026

Atos (ATOS) cuts $100M Jefferies ATM to $0, effective Feb 20, 2026 - Stock Titan

Feb 20, 2026

Feb 20, 2026

Atossa Genetics Inc. (NASDAQ:ATOS) Receives $95.00 Consensus PT from Analysts - Defense World

Feb 20, 2026

Feb 18, 2026

Atossa Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk - The Globe and Mail

Feb 18, 2026

Feb 18, 2026

Net debt of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Feb 18, 2026

Feb 17, 2026

Patterns Watch: What is Atossa Therapeutics Incs TAM Total Addressable Market2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - baoquankhu1.vn

Feb 17, 2026

Feb 17, 2026

Atossa Therapeutics, Inc. Balance Sheet – MUN:YAG - TradingView

Feb 17, 2026

Feb 17, 2026

Atossa Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Feb 17, 2026

Feb 17, 2026

Atossa Therapeutics to Participate in UCSF women health event - Traders Union

Feb 17, 2026

Feb 17, 2026

Basic earnings per share (basic EPS) of Atossa Therapeutics, Inc. – MUN:YAG - TradingView

Feb 17, 2026

Feb 16, 2026

Atossa Therapeutics: Key Developments and Upcoming Catalysts - AD HOC NEWS

Feb 16, 2026

Feb 16, 2026

Atossa Genetics Inc. (NASDAQ:ATOS) Short Interest Up 29.7% in January - Defense World

Feb 16, 2026

Feb 15, 2026

Is Atossa Therapeutics Inc. likely to announce a buybackJuly 2025 Rallies & Weekly Breakout Watchlists - mfd.ru

Feb 15, 2026

Feb 13, 2026

Is Atossa Therapeutics Inc. a speculative investmentWeekly Market Report & Free Technical Pattern Based Buy Signals - mfd.ru

Feb 13, 2026

Feb 12, 2026

Jobs Data: Is Atossa Therapeutics Incs growth already priced inJuly 2025 Price Swings & Stepwise Swing Trade Plans - baoquankhu1.vn

Feb 12, 2026

Feb 11, 2026

Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook - The Malaysian Reserve

Feb 11, 2026

Feb 11, 2026

Atossa Therapeutics issues letter to shareholders highlighting 2025 accomplishments and 2026 outlook - marketscreener.com

Feb 11, 2026

Feb 11, 2026

Atossa Therapeutics Issues 2026 Outlook and Strategic Update - TipRanks

Feb 11, 2026

Feb 11, 2026

Atossa Therapeutics Issues Letter To Shareholders Highlighting 2025 Accomplishments And 2026 Outlook - TradingView

Feb 11, 2026

Feb 11, 2026

Atossa Therapeutics Issues 2026 Shareholder Letter Highlighting Key Developments - TradingView

Feb 11, 2026

Feb 11, 2026

Can Atossa Therapeutics Inc. be recession proofJuly 2025 Momentum & Community Consensus Trade Signals - mfd.ru

Feb 11, 2026